Detalhe da pesquisa
1.
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.
Oncologist
; 26(8): e1418-e1426, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586299
2.
Key Elements in Adverse Drug Reactions Safety Signals: Application of Legal Strategies.
Cancer Treat Res
; 171: 47-59, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552656
3.
Drug safety: implications for the dermatologist and dermatopathologist.
Semin Cutan Med Surg
; 32(4): 195-8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24800425
4.
Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR).
EClinicalMedicine
; 31: 100693, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33554084
5.
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions.
PLoS One
; 14(7): e0219521, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31365527
6.
Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network.
J Community Support Oncol
; 14(2): 54-65, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26955658
7.
A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report.
J Oncol Pract
; 8(6): e158-67, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23598851